Home > Headlines > Novo Nordisk starts new CagriSema weightloss drug trial
Headlines

Novo Nordisk starts new CagriSema weightloss drug trial

Published by Global Banking and Finance Review

Posted on June 10, 2025

Featured image for article about Headlines

COPENHAGEN (Reuters) -Novo Nordisk has launched a new late-stage trial for its experimental next-generation obesity drug candidate, CagriSema, as it tries to reassure the market of its potential after disappointing data from two previous studies.

The Danish company made the announcement in an entry published on

"This study will look at how well CagriSema helps people living with obesity to lose weight and maintain the weight loss long-term," Novo Nordisk said in the entry.

(Reporting by Maggie Fick and Stine Jacobsen; Editing by Kirsten Donovan and Terje Solsvik)

Related Posts
Belarus' Lukashenko says US admission of failure to overturn re-election could revive relations
Belarus' Lukashenko says US admission of failure to overturn re-election could revive relations
Ukrainian drones hit tanker in Russia's Rostov port causing deaths, mayor says
Ukrainian drones hit tanker in Russia's Rostov port causing deaths, mayor says
Shares in South Korea's LGES drop more than 7% after Ford cancels EV battery deal
Shares in South Korea's LGES drop more than 7% after Ford cancels EV battery deal
Factbox-What we know about the shooting victims at Sydney's Bondi Beach Jewish event
Factbox-What we know about the shooting victims at Sydney's Bondi Beach Jewish event
Australia promises crackdown on hate as Bondi Beach shooting victim Matilda is farewelled
Australia promises crackdown on hate as Bondi Beach shooting victim Matilda is farewelled
UN, aid groups warn Gaza operations at risk from Israel impediments
UN, aid groups warn Gaza operations at risk from Israel impediments
IMF says Moldova's economy has unique growth opportunity, but reforms needed
IMF says Moldova's economy has unique growth opportunity, but reforms needed
UK firm Awendio Solaris plans $725 million solar plant with indigenous groups in Canada
UK firm Awendio Solaris plans $725 million solar plant with indigenous groups in Canada
AbbVie, several other pharma companies near MFN deal with Trump, sources say
AbbVie, several other pharma companies near MFN deal with Trump, sources say
US, Russia to hold talks in Miami this weekend, Politico reports
US, Russia to hold talks in Miami this weekend, Politico reports
EU reaches initial agreement on tighter EU-Mercosur safeguards
EU reaches initial agreement on tighter EU-Mercosur safeguards
Britain to overhaul benchmark rules to cut industry burden
Britain to overhaul benchmark rules to cut industry burden